Using a combination of RT - PCR and inverse-PCR techniques, we amplified, cloned and sequenced a full-length porcine
5-HT(1B) receptor cDNA derived from porcine cerebral cortex. Sequence analysis revealed 1170 bp encoding an open reading frame of 390
amino acids showing a 95% similarity with the human
5-HT(1B) receptor. The recombinant porcine 5-HT(1B)
cDNA was expressed in monkey Cos-7 cells and its pharmacological profile was determined by radioligand binding assay using [(3)H]-GR125743. The affinities of several agonists (L694247>
ergotamine > or =5-carboxamidotryptamine=
dihydroergotamine=5-HT>CP122638=
zolmitriptan>
sumatriptan) and putative antagonists (GR127935>
methiothepin>
SB224289>>
ritanserin>
ketanserin > or =BRL15572) correlated highly with those described for the recombinant human
5-HT(1B) receptor. In membranes obtained from cells co-expressing the porcine
5-HT(1B) receptor and a mutant G(alphao)Cys(351)Ile
protein,
5-HT and
zolmitriptan increased, while the
5-HT(1B) receptor antagonist
SB224289 decreased basal [(35)S]-
GTPgammaS binding, thus showing inverse agonism. The potency of
zolmitriptan in the [(35)S]-
GTPgammaS binding assay (pEC(50): 7.64+/-0.04) agreed with its affinity in displacing the antagonist [(3)H]-GR125743 (pK(i): 7.36+/-0.07). The
5-HT(1B) receptor mRNA was observed by RT-PCR in several blood vessels, cerebral cortex, cerebellum and trigeminal ganglion. In situ hybridization performed in frontal cerebral cortex sections revealed the expression of
5-HT(1B) receptor mRNA in pyramidal cells. In conclusion, we have cloned and established the amino acid sequence,
ligand binding profile and location of the porcine
5-HT(1B) receptor. This information may be useful in exploring the role of
5-HT(1B) receptor in pathophysiological processes relevant for novel
drug discovery in diseases such as
migraine.